Approximately $1.44 million has been committed to support vital Australian research into Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS).
Catch the latest from our Chief Investment Officer, Darren Thompson on SBS News' podcast, On the Money.